WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 1'7201 Infant (under 12 months) mortality rate: 422
GDP / capita (US$): 3'5911 Child (under 5 years) mortality rate: 492

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 28'541  28'152  27'769  27'393  27'023  24'829  20'555  16'027 
Births 623  623  621  617  611  578  704  576 
Surviving infants 595  595  593  589  583  548  660  533 
Pop. less than 5 years 2'989  2'962  2'874  2'823  2'761  2'881  3'254  2'491 
Pop. less than 15 years 8'274  8'275  8'267  8'312  8'371  9'258  8'436  6'595 
Female 15-49 years 8'034  7'935  7'836  7'713  7'581  6'455  4'787  3'661 

Number of reported case

(Click for retrospective incidence data for Uzbekistan)
Diphtheria 12 
Japanese encephalitis
Measles 476  117  80  3'943 
Mumps 2'300  1'160  1'418  1'454  1'862  3'949 
Pertussis 62  36  33  35  31  77  713 
Polio*
Rubella 23  24  454 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Uzbekistan)
Vaccine year result method % card seen                                                
BCG 2005  100  MICS   96.0  100  100  99  99  96  98 
DTP1 2005  99  MICS   96.0  100  99  99  97  96  97 
DTP3 2005  93  MICS   96.0  99  99  99  98  98  99 
HepB_BD          100  100  48  99  99 
HepB3 2005  90  MICS   96.0  99  99  99  98  91 
Hib3          99  99  99  98 
JapEnc         
MCV 2005  97  MICS   96.0  100  100  98  95  98  99 
MCV2          100  100  99 
PCV1         
PCV3         
Pol3 2005  90  MICS   96.0  100  100  99  99  98  99 
Rota1         
Rota_last         
Rubella1          100  100  95 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Uzbekistan)
BCG 99  99  99  99  96  98 
DTP1 99  99  99  99  99  99 
DTP3 99  99  99  98  98  99 
HepB3 99  99  99  98  91 
Hib3 99  99  99  98 
MCV 99  99  98  95  98  99 
PCV3
Pol3 99  99  99  99  98  99 
Rota_last

Number of districts in the country 196  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 3-5 days; Yes
DTwP 2, 3, 4, 16 months; Yes
DTwPHibHepB 2, 3, 4 months;
HepB Birth; 2, 3, 4 months; Yes
MMR 1, 6 years; Yes
OPV 3-5 days; 2, 3, 4, 16 months; 7 years; Yes
Td 7, 16 years;

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2010-2015  2010-2015  2010-2015  2006-2010  2006-2010  2006-2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 194  195    199    37  40 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes             

System performance

Total number of districts in country number 196  195  199  199  199  199  199 
Nº districts with DTP3 coverage >=80% number 196    199  199  199  191  199 
% of districts with DTP3 coverage >=80% From 0 to 100% 100    100  100  100  96  100 
Nº districts with measles (MCV1) coverage >=95% number 196    199  147  142     
% of districts with MCV1 coverage >=95% From 0 to 100% 100    100  74  71     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes   
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 41      58  55  64  64 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.